Cross Border Compliance with Attorney Benjamin L. England

Episode Summary: In this episode of Cross-Border compliance with Attorney Benjamin L. England, host Sean O'Connor and attorney Benjamin L. England delve into the complexities of FDA and customs compliance for importers. Benjamin, a former FDA attorney with over 40 years of experience, explains why FDA approval alone may not shield importers from customs enforcement issues. 
The discussion covers historical shifts post-NAFTA, the evolution of inter-agency cooperation, and the critical differences in how FDA and CBP evaluate imports. Benjamin shares insights into common pitfalls importers face, such as handling FDA and customs compliance separately, and offers practical strategies for integrating these processes to mitigate risks. Listeners will gain valuable knowledge on creating a cohesive compliance strategy that addresses both FDA and CBP requirements, ensuring smoother import operations.
Key Timestamps:00:01 – Introduction00:38 – Why FDA Approval Isn't Enough01:47 – Customs and FDA: Different Jurisdictions03:08 – Pre-NAFTA Compliance Challenges04:26 – Evolution of FDA and Customs Cooperation05:06 – Differences in Product Evaluation07:48 – Shipment Issues Despite FDA Compliance10:01 – FDA and USDA Regulatory Overlaps12:10 – Handling FDA and Customs Compliance Separately14:14 – CBP Discovering Additional Issues16:24 – Agencies Working Together on Compliance17:06 – Integrated Compliance Strategy Tips
About the Show:  Cross-Border compliance with Attorney Benjamin L. England is a podcast dedicated to helping businesses navigate the intricate world of FDA and customs regulations. Hosted by Sean O'Connor, the show features expert insights from attorney Benjamin L. England and other industry professionals. Each episode breaks down complex regulatory topics, offering practical advice for importers and exporters. 
Whether you're a seasoned professional or new to the field, the podcast provides valuable guidance on maintaining compliance and avoiding costly enforcement actions. With a focus on clarity and actionable strategies,  Cross-Border compliance with Attorney Benjamin L. England  is your go-to resource for Cross-Border compliance

Episode Summary: In this episode of Cross-Border compliance with Attorney Benjamin L. England, host Sean O'Connor and former FDA attorney Benjamin L. England delve into the complexities of tariff refund claims and the resulting customs scrutiny for importers. They discuss the Supreme Court's decision that struck down certain tariffs, leading to a new electronic system, CAPE, designed to facilitate refunds. Despite its implementation, only a small percentage of refunds have been processed, as customs audits and evaluations slow the process.
The conversation highlights the challenges importers face, such as dealing with FDA holds and determining the true party in interest for refunds. England emphasizes the importance of conducting internal audits to ensure compliance and avoid potential penalties. This episode provides valuable insights for importers navigating the intricate landscape of tariff refunds and customs regulations.
Key Timestamps:00:01 – Introduction00:07 – Overview of Tariff Refund Claims00:58 – Supreme Court's Impact on Tariffs02:16 – Introduction of the CAPE System03:39 – Challenges in Receiving Refunds04:52 – Customs' Scrutiny on Past Import Activity06:34 – Impact of Customs Audits on Refunds07:04 – When Refund Reviews Become Enforcement Issues09:05 – Balancing Tariff Refunds with FDA Holds11:00 – Importer of Record and Refund Claims12:39 – Civil Disputes Over Refunds14:52 – Role of Couriers in Refund Claims16:39 – Litigation Around FDA-Regulated Goods17:11 – Preparing for Refund Claims: Internal Audits
About the Show: Cross-Border compliance with Attorney Benjamin L. England is a podcast dedicated to providing importers and trade professionals with crucial insights into cross-border compliance. Hosted by Sean O'Connor and featuring expert guests like Benjamin L. England, the show covers a wide range of topics, including FDA regulations, customs enforcement, and international trade laws. With a focus on clarity and practical advice, Cross-Border compliance with Attorney Benjamin L. England aims to help listeners navigate the complex world of import compliance and stay informed about the latest developments in the industry.

Episode Summary:
In this episode, Attorney Benjamin England sheds light on the nuances of voluntary disclosures in FDA and Customs enforcement. He explains the differences between mandatory disclosures in FDA for safety-related issues and the need for prior disclosures in Customs for duty-related matters. The discussion covers scenarios where voluntary disclosures can mitigate risks and instances where they could potentially lead to increased exposure.
Key Timestamps:
00:00 – Introduction: Voluntary Disclosures in FDA and Customs Compliance
00:40 – Key Differences: FDA vs. Customs Disclosure
01:30 – FDA: Importers' Obligation to Report Safety Issues
03:00 – Compliance Responsibility: Importers vs. Manufacturers
04:30 – Increased Compliance for Direct-to-Consumer Imports
05:00 – No Formal Voluntary Disclosure System at FDA
06:00 – Customs: Prior Disclosure for Duty-Related Errors
07:30 – Proactive Reporting Reduces Penalties and Risk
09:00 – Strategic Disclosure Decisions in FDA Cases
10:00 – Customs Disclosure Limits Financial Penalties vs. Duties
11:30 – IRS Analogy: Comparing Customs to Tax Audits
12:30 – When Disclosure May Not Be Necessary
13:30 – Resolving Import Alerts and FDA Detentions
15:00 – High-Risk Customs Issues: Duties and FTAs
16:30 – Customs Investigations: Up to Seven Years of Exposure
17:30 – Factors in Disclosure Decisions: Risk, Exposure, History
18:30 – Global Variations in Compliance Risk Tolerance
19:20 – Conclusion and Key Takeaways
About the Show:
*FDA Imports: Cross-Border compliance with Attorney Benjamin L. England* is a podcast series hosted by Attorney Benjamin England, focusing on cross-border compliance issues in FDA and Customs regulations. The show provides expert insights and guidance for companies navigating the complexities of international trade and regulatory oversight.

Episode Summary:
In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor and attorney Benjamin L. England delve into the complexities of customs post-entry audits, focusing on CF-28s and CF-29s. Benjamin, founder of FDAImports.com and a former FDA regulatory counsel, explains why importers shouldn't assume their responsibilities end once a shipment clears customs. He highlights the importance of understanding the conditional nature of customs releases and the potential for audits years after entry. The discussion covers the differences between CF-28 and CF-29 forms, the types of issues that can trigger audits, and the implications of failing to comply with customs regulations. Benjamin also offers practical advice on maintaining proper documentation and the significance of a well-drafted purchase order to mitigate risks. This episode is essential for importers looking to navigate the intricate landscape of FDA and customs compliance effectively.
Key Timestamps:
00:01 – Introduction
00:07 – Overview of Customs Post-Entry Audits
00:53 – Conditional Release of Goods by Customs
01:58 – Role of FDA in Customs Compliance
03:08 – Customs Examination and Duty Calculation
04:41 – Understanding CF-28 Forms and Compliance
05:48 – Differences Between CF-28 and CF-29
07:42 – Triggers for Post-Entry Audits
10:26 – Record Keeping and Statute of Limitations
12:23 – Importance of Accurate Declarations
14:04 – FDA Involvement in Customs Investigations
16:08 – Systems to Reduce Post-Entry Audit Risks
About the Show:
FDA Imports: Cross-Border Compliance is a podcast designed for businesses navigating the complex world of FDA regulations and international trade. Hosted by industry experts, the show provides insights into compliance strategies, regulatory updates, and best practices for managing cross-border transactions. With a focus on clarity and practical advice, each episode aims to equip listeners with the knowledge they need to successfully import and export goods while adhering to legal requirements. Whether you're a seasoned importer or new to the field, this podcast offers valuable guidance to help you stay compliant and avoid costly pitfalls.

Episode Summary:
In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor is joined by Attorney Benjamin England, founder of FDAImports.com and a former FDA regulatory counsel. They delve into the complexities of first-time FDA-regulated imports, highlighting common mistakes that lead to shipment delays, detentions, or refusals. Benjamin emphasizes the importance of understanding FDA requirements from the outset, including proper documentation and compliance checks before goods leave the foreign supplier. They discuss assumptions that new importers make about FDA requirements, the role of timing in import processes, and the impact of labeling and registration details on shipments. The episode provides valuable insights for businesses entering the US market, offering practical strategies to avoid common pitfalls and ensure smooth import operations.
Key Timestamps:
00:00 – Introduction
00:26 – Common Mistakes in First-Time Imports
01:12 – Importance of Early Transaction Compliance
02:39 – Assumptions About FDA Requirements
03:47 – Challenges with Proprietary Information
05:03 – Role of Customs Brokers
06:01 – FDA's Authority at the Border
07:07 – Labeling and Product Compliance Issues
08:15 – Differing FDA Expectations by Product Type
10:18 – Timing and Its Impact on Imports
12:33 – Perishable Goods and Timing Challenges
14:17 – Case Study: Dietary Supplements
17:08 – Cosmetic Products with Drug Claims
19:18 – Impact of Initial Non-Compliance on Future Imports
About the Show:
FDA Imports: Cross-Border Compliance is a podcast dedicated to helping businesses navigate the intricate world of FDA regulations and international trade. Hosted by industry experts, the show provides insightful discussions on compliance strategies, regulatory updates, and best practices for importing FDA-regulated products. Whether you're a seasoned importer or new to the field, this podcast offers valuable knowledge to ensure your business meets regulatory standards and avoids common pitfalls. With a focus on clarity and practical advice, FDA Imports is your go-to resource for staying informed and compliant in the ever-evolving landscape of cross-border trade.

Episode Summary:In this episode of *FDA Imports: Cross-Border Compliance* Benjamin England delves into the significance of TrumpRX.gov in the context of drug pricing policy and pharmaceutical importation. Exploring the complexities of pharmaceutical pricing disparities between the US and Europe, Ben sheds light on the regulatory changes initiated by the Trump administration to facilitate the importation of pharmaceuticals, offering a potential solution to high drug costs for American consumers.
Key Timestamps:00:00 – Introduction02:30 – TrumpRX.gov: A Game-Changer in Pharmaceutical Pricing06:45 – The Implications of Temporary Programs on Industry Players10:15 – Enforcement Approaches to Gray Market Rx Drugs14:50 – Mitigating Risks in Pharmaceutical Importation18:25 – The Complexities of Regulatory Scrutiny and Sourcing Patterns
About the Show:*FDA Imports: Cross-Border Compliance* provides expert insights into cross-border compliance issues related to FDA regulations and international trade. Led by Attorney Benjamin England, the show navigates the intricate landscape of FDA oversight, regulatory compliance, and importation challenges faced by businesses worldwide.

Episode Summary:In this episode of FDA Imports: Cross Border Compliance with Attorney Benjamin England sheds light on the FDA's recent enforcement discretion around color additives, impacting labeling regulations and creating confusion for importers. He clarifies the distinction between natural and synthetic colors, discusses the FDA's changing approach to artificial colors claims, and outlines the compliance challenges importers may face in light of this guidance.
Key Timestamps:00:00 – Introduction02:15 – Differentiating between natural and synthetic colors04:30 – FDA's enforcement discretion on artificial colors claims07:45 – Compliance implications for importers11:20 – Potential risks and considerations for companies15:00 – Navigating FDA's evolving enforcement expectations
About the Show:*FDA Imports: Cross Border Compliance with Attorney Benjamin England* is the go-to podcast for insights into cross-border compliance issues, hosted by industry expert Benjamin England. Join as the show unravel the complexities of FDA regulations and provide valuable guidance for businesses dealing with import compliance challenges.

Episode Summary:In this episode, Benjamin England delves into the complexities of FDA compliance for importers and customs brokers. He highlights the common misunderstandings that lead to compliance breakdowns and emphasizes the crucial role importers play in ensuring regulatory adherence. From the responsibilities of customs brokers to the challenges faced at the border, this episode offers valuable insights for companies navigating FDA regulations in international trade.
Key Timestamps:00:00 – Introduction to FDA Compliance & Broker Responsibilities01:20 – Importer vs. Customs Broker Roles Explained03:00 – Where the Assumption Breaks Down04:30 – Broker Limitations & Experience Gaps06:00 – Common Communication Failures Before Shipment07:30 – What Happens at the Border When Compliance Fails09:00 – Missing Data, Approvals & Entry Errors10:30 – Who Bears the Risk: Importer vs Manufacturer12:00 – Consequences: Refusal, Export, or Destruction13:30 – Broker Liability & Contract Limitations14:50 – Managing Risk & Verifying Broker Accuracy16:00 – Structuring Responsibilities & Contracts
About the Show:*FDA Imports* is a podcast series hosted by Benjamin England, focusing on the intricate landscape of FDA compliance in cross-border trade. With expert insights and practical guidance, the show equips businesses with the knowledge needed to navigate regulatory challenges effectively.

Episode Summary:Benjamin England delves into the intricate world of FDA corrective action plans, shedding light on why many plans fail to meet FDA standards despite companies' efforts. From understanding the root cause to the importance of documentation, Ben provides invaluable insights into creating effective action plans that satisfy FDA requirements.
Key Timestamps:00:00 – Introduction to FDA Imports & Corrective Action Plans01:20 – What is a CAPA & When FDA Requires It03:10 – Import Alerts, Root Cause Analysis & CAPA Process05:00 – Why CAPAs Fail: Root Cause Challenges06:40 – Investigations & Common Mistakes in CAPAs08:20 – Importance of Documentation & Evidence10:00 – Implementation Records & Proving Compliance11:40 – Systemic Fix vs Temporary Fix13:10 – Supplier Risks & Real-World Examples14:40 – Timing of CAPA & Impact on Import Status16:00 – Ongoing Imports & Strategic Timing Considerations17:00 – FSVP, Verification & FDA Expectations
About the Show:*FDA Imports* is your go-to resource for navigating the complex world of FDA compliance in international trade. Join us as we unravel the nuances of FDA regulations, offering expert guidance to ensure your company stays in line with FDA requirements.

Episode Summary:
In this episode, attorney Benjamin England discusses the recent Supreme Court ruling on IEEPA tariffs and the implications for companies navigating the complex world of international trade and FDA oversight. From constitutional issues to refund mechanisms, Benjamin provides valuable insights into the evolving tariff landscape.
Key Timestamps:
00:00 – Introduction
01:30 – IEEPA Tariffs Ruling
05:45 – Constitutional Implications
08:20 – Refund Mechanisms
11:10 – Legal Landscape Analysis
...continues with detailed insights
About the Show:
*FDA Imports* is a podcast hosted by attorney Benjamin England, focusing on cross-border compliance issues related to FDA regulations and international trade. Join us for expert insights and discussions on navigating complex legal challenges in the import industry.